on NANOBIOTIX (EPA:NANO)
Nanobiotix will participate in the Jefferies London Healthcare conference
Nanobiotix, a French biotechnology company, will participate in the Jefferies London Healthcare Conference on November 17, 2025. Focused on nanoparticles, the company develops innovative treatments for cancer and other diseases. Representatives Laurent Levy, co-founder, and Bart van Rhijn, CFO, will participate in a live discussion. The event will take place in London and will be streamed on the Nanobiotix website. This participation marks an important step in increasing the company's visibility and sharing its clinical advancements with the scientific community and investors interested in oncology innovation.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NANOBIOTIX news